View post: The One Workout Mistake Most Guys Make in Their 30s and Pay For in Their 40s, According to a Veteran Trainer James Van Der Beek died at 48 from stage 3 colon cancer, diagnosed in 2023.
New research pinpoints exactly how much alcohol is linked to an increased colon cancer risk Cara Lynn Shultz is a writer-reporter at PEOPLE. Her work has previously appeared in Billboard and Reader's ...
Reginald is a Video Game Guide Contributor at GameRant. He has 8 years of professional experience producing walkthroughs and guides for video game media websites, focusing on JRPGs and Gacha games.
Jenna Scott remembers the joy of being pregnant with her first and only child. She also remembers the immense abdominal pain. During her pregnancy, she let her doctors know about the persistent ...
Most types of cancer have become less deadly over time in adults younger than age 50 in the U.S. but colon and rectum cancers continue to cost lives at alarming rates, according to a new report from ...
Ozempic and Wegovy might help people avoid colon cancer as well as promote weight loss or control diabetes, a new study says. People who took a GLP-1 drug were 36% less likely to get colon cancer than ...
Forbes contributors publish independent expert analyses and insights. David Jagneaux is a writer and analyst, covering MMOs and retro games. Unlike typical emulation setups that rely on downloaded ...
The Old Peace introduces a new layer to the complicated cake that is modding in Warframe, adding Operator Mods that can be used to increase the power of your Operator, Amp, and newly available Tauron ...
EVERY DAY, A CANCER DIAGNOSIS CHANGES SOMEONE’S LIFE FOREVER AND ACCORDING TO NEW RESEARCH, IS BEING SAID MORE OFTEN TO YOUNG PEOPLE WITH COLON CANCER. BLAKE EASON SPOKE EXCLUSIVELY WITH TWO SISTERS ...
After completing a degree in Film, Television, and Cultural Studies at Manchester Metropolitan University, I decided to pursue my love of writing and video games by entering the world of video game ...
Patients with colon cancer using GLP-1 receptor agonists (the class of drugs behind treatments like Ozempic, Wegovy, and Mounjaro) had substantially lower five-year death rates than those not using ...